These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 3368333
1. Highly sensitive determination of TSH in the follow-up of TSH-suppressive therapy of patients with differentiated thyroid cancer. Mann K, Saller B, Mehl U, Hörmann R, Moser E. Nuklearmedizin; 1988 Feb; 27(1):24-8. PubMed ID: 3368333 [Abstract] [Full Text] [Related]
2. [Hormonal therapy in differentiated carcinoma of the thyroid gland]. Francia G, Davì MV, Petroziello A, Sussi PL. Chir Ital; 1994 Feb; 46(4):56-8. PubMed ID: 7882445 [Abstract] [Full Text] [Related]
3. The usefulness of a sensitive thyrotrophin assay in the fine adjustment of thyroxine therapy following ablation for carcinoma. de Lange WE, Sluiter WJ, Doorenbos H. Neth J Med; 1989 Aug; 35(1-2):11-7. PubMed ID: 2779691 [Abstract] [Full Text] [Related]
4. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G, Testa A, Giacomini D, Carrozza C, Maussier ML, Valenza V, D'Errico GF. Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [Abstract] [Full Text] [Related]
5. Surveillance of TSH-suppressive levothyroxine treatment in thyroid cancer patients: TRH testing versus basal TSH determination by a third generation assay. Görges R, Saller B, Eising EG, Quadbeck B, Mann K, Bockisch A. Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):355-60. PubMed ID: 12397535 [Abstract] [Full Text] [Related]
7. Central hypothyroidism--various types of TSH responses to TRH stimulation. Trejbal D, Sulla I, Trejbalová L, Lazúrová I, Schwartz P, Machánová Y. Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012 [Abstract] [Full Text] [Related]
13. The immunofluorometric TSH assay as first-line test for suspected thyroid dysfunction. van Hamersvelt HW, Kreutzer HJ, Tertoolen JF, Thijssen JH, Koppeschaar HP. Neth J Med; 1989 Oct; 35(3-4):192-200. PubMed ID: 2689895 [Abstract] [Full Text] [Related]
14. Comparison of the analytical and clinical performances of three thyrotropin immunoassay kits. Minebois-Villégas A, Rohmer V, Rachédi F, Berrut G, Boux de Casson-Raimbeau F, Wion-Barbot N, Bigorgne JC, Jallet P. Ann Biol Clin (Paris); 1995 Oct; 53(7-8):413-8. PubMed ID: 8597312 [Abstract] [Full Text] [Related]
15. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial? Rana S, Nunlee-Bland G, Valyasevi R, Iqbal M. Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500 [Abstract] [Full Text] [Related]
16. [Can the thyrotropin (TSH) suppressive dose of L-thyroxine (T4) be individually predicted in athyroid patients?]. Kainz H, Weissel M. Acta Med Austriaca; 1990 Dec; 17(2-3):50-4. PubMed ID: 2120901 [Abstract] [Full Text] [Related]
17. [The negative TRH test: new differential assessment using a sensitive TSH assay]. Lind P, Klima G, Költringer P, Langsteger W, Eber O. Schweiz Med Wochenschr; 1988 Aug 09; 118(31-32):1130-4. PubMed ID: 3140373 [Abstract] [Full Text] [Related]
19. [Evaluation of TSH suppression using a 3d-generation TSH assay: diagnostic and therapeutic consequences]. Exer P, Staub JJ, Zulewski H, Müller B, Kunz M, Huber P. Schweiz Med Wochenschr; 1992 Dec 26; 122(51-52):1964-7. PubMed ID: 1475661 [Abstract] [Full Text] [Related]
20. [Diagnostic significance of immunoradiometric serum TSH determination]. Passath A, Leb G, Warnkross H. Wien Med Wochenschr; 1986 Nov 30; 136(21-22):550-3. PubMed ID: 3103337 [Abstract] [Full Text] [Related] Page: [Next] [New Search]